A human monoclonal antibody against HBsAg for the prevention and treatment of chronic HBV and HDV infection

A human monoclonal antibody against HBsAg for the prevention and treatment of chronic HBV and HDV infection

Background & Aims: Elimination of chronic HBV/HDV infection remains a major global health challenge. Targeting excessive hepatitis B surface antigen (HBsAg) release may provide an interesting window of opportunity to break immune tolerance and to achieve a functional cure using additional an...

Full description

Bibliographic Details
Main Authors: Rani Burm, Freya Van Houtte, Lieven Verhoye, Ahmed Atef Mesalam, Sandra Ciesek, Philippe Roingeard, Heiner Wedemeyer, Geert Leroux-Roels, Philip Meuleman
Format: Article
Language:English
Published: Elsevier 2023-03-01
Series:JHEP Reports
Subjects:
Viral hepatitis
hepatitis B
hepatitis D
human monoclonal antibody
hepatitis B surface antigen
prevention
Online Access:http://www.sciencedirect.com/science/article/pii/S258955592200218X

Internet

http://www.sciencedirect.com/science/article/pii/S258955592200218X

Similar Items